Consolidated Statements of Changes in Members' Equity and Stockholders' Equity - USD ($) $ in Thousands	Total	Class A [Member]	Class B [Member]	Members' Equity [Member]	Common Stock [Member] Class A [Member]	Common Stock [Member] Class B [Member]	Additional Paid-in capital [Member]	Retained Earnings [Member]	Non-Controlling Interests [Member]
Beginning Balance at Dec. 31, 2022	$ 75,929			$ 42,729					$ 33,200
Contributions	889								889
Non-cash equity contribution	225								225
Net income	37,720			23,902					13,818
Distributions	(54,904)			(38,422)					(16,482)
Ending Balance at Dec. 31, 2023	59,859			28,209					31,650
Net income	(71,033)
Net income prior to Corporate Reorganization	39,110			22,760					16,350
Contributions prior to Corporate Reorganization	2,107								2,107
Distributions prior to Corporate Reorganization	(50,329)			(36,050)					(14,279)
Non-cash equity contribution prior to Corporate Reorganization	4,989								4,989
Conversion of non-controlling interest into Guardian Pharmacy, LLC common units				34,169					(34,169)
Conversion of Restricted Interest Unit awards into Guardian Pharmacy, LLC common units	142,498			142,498
Conversion of Guardian Pharmacy, LLC common units into Class B common stock of Guardian Pharmacy Services, Inc. (Shares)						54,094,232
Conversion of Guardian Pharmacy, LLC common units into Class B common stock of Guardian Pharmacy Services, Inc.				$ (191,586)		$ 54	$ 9,185	$ 182,347
Issuance of Class A common stock, net of costs (Shares)					9,200,000
Issuance of Class A common stock, net of costs	106,762				$ 9		106,753
Payments to Class B common stock stockholders of $1.02 per share	(55,176)							(55,176)
Recognition of deferred tax asset, net from Corporate Reorganization	5,973						5,973
Net income (loss) attributable to Guardian Pharmacy Services, Inc.	(110,047)	$ (16,261)	$ (93,786)					(110,047)
Share-based compensation forfeitures (Shares)						(7,074)
Net income (loss) attributable to non-controlling interest subsequent to Corporate Reorganization	(96)								(96)
Share-based compensation forfeitures	(1)						(1)
Contributions Subsequent To Corporate Reorganization	651								651
Non-cash equity contribution subsequent to Corporate Reorganization	286								286
Distributions Subsequent To Corporate Reorganization	(184)								(184)
Equity-based compensation subsequent to Corporate Reorganization	3,574						3,574
Ending Balance at Dec. 31, 2024	$ 149,976				$ 9	$ 54	$ 125,484	$ 17,124	$ 7,305
Ending Balance (Shares) at Dec. 31, 2024					9,200,000	54,087,158